Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Platelet Aggregation Devices Market by Product (Reagents, Systems, Consumables and Accessories), by Application (Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Clinical Applications (Bleeding Disorders, Antiplatelet Therapy, and Trauma)) and by End User (Diagnostic Laboratories, Research and Academic Institutes, Standalone Hospitals, Other End Users (Pharmaceutical Biotechnology Companies and Blood Banks)): Global Opportunity Analysis and Industry Forecast, 2023-2032

A09091

Pages: NA

Charts: NA

Tables: NA

Platelet Aggregation Devices Market Outlook - 2027

Platelet Aggregation Devices Market is expected to grow in the upcoming years due to increase in output for pharmaceutical companies for developing platelet aggregation techniques. Platelet aggregation is a test done to test the chances of bleeding of patient during the surgery. It is a type of procedure in which human cells are included in vessel contraction, homeostasis and repair bleeding. 

Platelet aggregation test includes venipuncture in non-clotting medium, which is produced by centrifugation process for extracting the plasma. In this process aggregometers are also used. Platelet aggregation process includes various medical devices which provide precise control over the active blood flow and thus controls the extent of formation of platelet thrombus. Platelet aggregation devices include devices such as platelet function analyzer (PFA), aggregometers, platelet collection systems and platelet function centrifuge.

COVID-19 scenario analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Considering these factors, Covid -19 is expected to have significant impact on Platelet Aggregation Devices Market.

Top Impacting factors:

  • Factors such as rise in awareness and acceptance for the platelet related treatments in diseases such as cancer are driving the growth of platelet aggregation devices market.
  • Technological advancements made in platelet aggregation is boosting the market growth. Increase in demand for platelet screening programs in identification of diseases such as HIV and dengue has resulted in the surge for the platelet aggregation devices market.
  • Increase in number of collaboration among academic and industry research about clinical studies is boosting the platelet aggregation devices market to grow.
  • Restrain factors such as decrease in opportunity at the end user level and high costs regarding purchase of devices is lowering the growth of platelet aggregation devices market. Requirement In large amount of blood for the aggregation technique can decrease the usage of platelet aggregation technique which can affect the market.

Key benefits of the report:

  • This study presents the analytical depiction of the global platelet aggregation devices market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Platelet Aggregation Devices Market share.
  • The current market is quantitatively analyzed to highlight the Platelet Aggregation Devices Market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Platelet Aggregation Devices Market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Platelet Aggregation Devices Market Report:

  • What are the leading market players active in Platelet Aggregation Devices Market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the market growth & why?

 Key Market Segments

  • By Product
    • Reagents
    • Systems
    • Consumables and Accessories
  • By Application
    • Clinical Applications
    • Research Applications
    • Cardiovascular Applications
    • Orthopedic Applications
    • Other Clinical Applications (Bleeding Disorders, Antiplatelet Therapy, and Trauma)
  • By End User
    • Diagnostic Laboratories
    • Research and Academic Institutes
    • Standalone Hospitals
    • Other End Users (Pharmaceutical & Biotechnology Companies and Blood Banks)
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Helena Laboratories Corporation
  • Siemens AG
  • F. Hoffmann La-Roche Ltd.
  • Accriva Diagnostics
  • Bio/Data Corporation.
  • Haemonetics Corporation
  • Sysmex Corporation
  • Aggredyne, Inc

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Reagents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Systems

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Consumables And Accessories

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Clinical Applications

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Research Applications

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cardiovascular Applications

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Orthopedic Applications

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Other Clinical Applications (Bleeding Disorders, Antiplatelet Therapy, And Trauma)

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: PLATELET AGGREGATION DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Diagnostic Laboratories

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Research And Academic Institutes

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Standalone Hospitals

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Other End Users (Pharmaceutical And Biotechnology Companies And Blood Banks)

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: PLATELET AGGREGATION DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Platelet Aggregation Devices Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Platelet Aggregation Devices Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Platelet Aggregation Devices Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Platelet Aggregation Devices Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Platelet Aggregation Devices Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Platelet Aggregation Devices Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Platelet Aggregation Devices Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Platelet Aggregation Devices Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Platelet Aggregation Devices Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Platelet Aggregation Devices Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Platelet Aggregation Devices Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Platelet Aggregation Devices Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Platelet Aggregation Devices Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Platelet Aggregation Devices Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Platelet Aggregation Devices Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Platelet Aggregation Devices Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Platelet Aggregation Devices Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Platelet Aggregation Devices Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Platelet Aggregation Devices Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Platelet Aggregation Devices Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Platelet Aggregation Devices Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Platelet Aggregation Devices Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Platelet Aggregation Devices Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Platelet Aggregation Devices Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Platelet Aggregation Devices Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. F. Hoffmann La-Roche Ltd.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Siemens AG

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Haemonetics Corporation

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Sysmex Corporation

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Helena Laboratories Corporation

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Accriva Diagnostics

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Aggredyne, Inc

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Bio/Data Corporation.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR SYSTEMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR CONSUMABLES AND ACCESSORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR OTHER CLINICAL APPLICATIONS (BLEEDING DISORDERS, ANTIPLATELET THERAPY, AND TRAUMA), BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR STANDALONE HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL PLATELET AGGREGATION DEVICES MARKET FOR OTHER END USERS (PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES AND BLOOD BANKS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA PLATELET AGGREGATION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. U.S. PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. U.S. PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. U.S. PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. CANADA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. CANADA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. CANADA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE PLATELET AGGREGATION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. ITALY PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. ITALY PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. ITALY PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. UK PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. UK PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. UK PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC PLATELET AGGREGATION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. CHINA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. CHINA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. CHINA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. INDIA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. INDIA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. INDIA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA PLATELET AGGREGATION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. UAE PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 100. UAE PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. UAE PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA PLATELET AGGREGATION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA PLATELET AGGREGATION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA PLATELET AGGREGATION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. F. HOFFMANN LA-ROCHE LTD.: KEY EXECUTIVES
  • TABLE 109. F. HOFFMANN LA-ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 110. F. HOFFMANN LA-ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 111. F. HOFFMANN LA-ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 112. F. HOFFMANN LA-ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. SIEMENS AG: KEY EXECUTIVES
  • TABLE 114. SIEMENS AG: COMPANY SNAPSHOT
  • TABLE 115. SIEMENS AG: OPERATING SEGMENTS
  • TABLE 116. SIEMENS AG: PRODUCT PORTFOLIO
  • TABLE 117. SIEMENS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. HAEMONETICS CORPORATION: KEY EXECUTIVES
  • TABLE 119. HAEMONETICS CORPORATION: COMPANY SNAPSHOT
  • TABLE 120. HAEMONETICS CORPORATION: OPERATING SEGMENTS
  • TABLE 121. HAEMONETICS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 122. HAEMONETICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 124. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. SYSMEX CORPORATION: OPERATING SEGMENTS
  • TABLE 126. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. HELENA LABORATORIES CORPORATION: KEY EXECUTIVES
  • TABLE 129. HELENA LABORATORIES CORPORATION: COMPANY SNAPSHOT
  • TABLE 130. HELENA LABORATORIES CORPORATION: OPERATING SEGMENTS
  • TABLE 131. HELENA LABORATORIES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 132. HELENA LABORATORIES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. ACCRIVA DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 134. ACCRIVA DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 135. ACCRIVA DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 136. ACCRIVA DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 137. ACCRIVA DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. AGGREDYNE, INC: KEY EXECUTIVES
  • TABLE 139. AGGREDYNE, INC: COMPANY SNAPSHOT
  • TABLE 140. AGGREDYNE, INC: OPERATING SEGMENTS
  • TABLE 141. AGGREDYNE, INC: PRODUCT PORTFOLIO
  • TABLE 142. AGGREDYNE, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. BIO/DATA CORPORATION.: KEY EXECUTIVES
  • TABLE 144. BIO/DATA CORPORATION.: COMPANY SNAPSHOT
  • TABLE 145. BIO/DATA CORPORATION.: OPERATING SEGMENTS
  • TABLE 146. BIO/DATA CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 147. BIO/DATA CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PLATELET AGGREGATION DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PLATELET AGGREGATION DEVICES MARKET
  • FIGURE 3. SEGMENTATION PLATELET AGGREGATION DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PLATELET AGGREGATION DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPLATELET AGGREGATION DEVICES MARKET
  • FIGURE 11. PLATELET AGGREGATION DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. PLATELET AGGREGATION DEVICES MARKET FOR REAGENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. PLATELET AGGREGATION DEVICES MARKET FOR SYSTEMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. PLATELET AGGREGATION DEVICES MARKET FOR CONSUMABLES AND ACCESSORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. PLATELET AGGREGATION DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. PLATELET AGGREGATION DEVICES MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. PLATELET AGGREGATION DEVICES MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. PLATELET AGGREGATION DEVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. PLATELET AGGREGATION DEVICES MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. PLATELET AGGREGATION DEVICES MARKET FOR OTHER CLINICAL APPLICATIONS (BLEEDING DISORDERS, ANTIPLATELET THERAPY, AND TRAUMA), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. PLATELET AGGREGATION DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. PLATELET AGGREGATION DEVICES MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. PLATELET AGGREGATION DEVICES MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. PLATELET AGGREGATION DEVICES MARKET FOR STANDALONE HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. PLATELET AGGREGATION DEVICES MARKET FOR OTHER END USERS (PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES AND BLOOD BANKS), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: PLATELET AGGREGATION DEVICES MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. F. HOFFMANN LA-ROCHE LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. F. HOFFMANN LA-ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. F. HOFFMANN LA-ROCHE LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. SIEMENS AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. SIEMENS AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. SIEMENS AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. HAEMONETICS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. HAEMONETICS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. HAEMONETICS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. SYSMEX CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. HELENA LABORATORIES CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. HELENA LABORATORIES CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. HELENA LABORATORIES CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. ACCRIVA DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. ACCRIVA DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. ACCRIVA DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. AGGREDYNE, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. AGGREDYNE, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. AGGREDYNE, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. BIO/DATA CORPORATION.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. BIO/DATA CORPORATION.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. BIO/DATA CORPORATION.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Platelet Aggregation Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved